The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Mark Gilbert named chief of Neuro-Oncology Branch at NIH

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

MARK GILBERT was named chief of the Neuro-Oncology Branch at the NIH, within the Center for Cancer Research of NCI.

Gilbert was previously deputy chairman of the Department of Neuro-Oncology at MD Anderson Cancer Center.

The Neuro-Oncology Branch is a cooperative program between the NCI and the National Institute for Neurological Disorders and Stroke. Established in 2000, the NOB became one of the first trans-institutional initiatives at the NIH.

Gilbert has served as co-chair of the Brain Tumor Committee for the Radiation Therapy Oncology Group since 2010, and has been the primary investigator on a number of pivotal studies in the field of neuro-oncology. He is expected to begin his new role in late November.

Table of Contents

YOU MAY BE INTERESTED IN

California state-funded institute scraps selection process that put cancer projects at a disadvantage
Cancer researchers are resubmitting applications to the California Institute for Regenerative Medicine

The California Institute for Regenerative Medicine, a state agency tasked with awarding billions of dollars of scientific funding for stem cell and gene therapy, has rescinded a controversial policy that was disrupting the flow of funding to cancer research.
By Sara Willa Ernst
Cancer Policy

President’s budget request would cap indirect costs and fully fund all NIH research projects upfront

NCI has emerged relatively unscathed in the president’s FY 2027 budget request that would slash $15.8 billion from HHS funding, cut NIH overall by about 10%, eliminate three NIH institutes and centers, and move the Institute for Environmental Health Sciences and its circa $1 billion budget out of NIH.
By Claire Marie Porter and Jacquelyn Cobb
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account